News & Events about IP just for you

WJIP asks – What does being IP inclusive mean to you?

12/12/17 As founding signatories of the IP Inclusive Charter, Wynne-Jones asks several of its senior trainees what being IP inclusive means to them.

New IP service helps ‘maximise’ patent commercial success

24/11/17 Entrepreneurs, inventors, and start-ups are getting expert advice to maximise their patent’s commercial success thanks to a new service launched by Wynne-Jones IP. The intellectual property firm, which provides advice relating to all aspects of patents, trade marks, copyright, and designs, has launched its innovative Patent Analytics service this month.

IP Crime and Enforcement Advice for Businesses

22/11/17 Intellectual property rights infringement happens when a product, creation or invention protected by IP laws are exploited, copied or otherwise used without the permission of the legal owner of those rights. What can you do when you have been accused of infringing someone’s IP rights?

Less is More with the launch of Wynne Jones IP’s streamlined Intellectual Property renewals service

02/10/17 Businesses looking to renew their intellectual property are benefiting from a “significantly streamlined” service thanks to Wynne Jones IP. The intellectual property firm has launched its improved service, aimed at making the IP renewals process more cost effective, transparent, and efficient.

O2 climb

08/06/17 Four members of staff will be scaling London’s O2 Arena in a bid to raise vital funds for people affected by brain injury.

WYNNE-JONES IP CELEBRATES GROWTH WITH LAUNCH OF LONDON OFFICE

01/06/17 Wynne-Jones IP celebrates opening its first London office in the heart of the city's legal district.

Unitary Patent: renewal fees decided

17/05/17 At long last, the EPO have made a decision on the renewal fee structure for the Unitary Patent (UP).

Wynne Jones senior trainee patent attorney delighted with CIPA Informals regional role

12/05/17 A senior trainee patent attorney at Wynne Jones IP is “delighted” to have taken on an influential regional role.

Training Academy Impresses with Results

03/04/17 Ten flourishing staff members have achieved ‘exceptional’ exam success in Wynne-Jones IP’s first successful year of running their training academy.

How lack of data may have cost a pharmaceutical giant billions

28/02/17 With 2015 sales of US$1.6Bn and 2017 projected sales of US$2Bn, Bristol-Myers Squibb’s (BMS’) anti-cancer drug dasatinib (Sprycel®) is highly successful and of great interest to competitors. A February 2017 decision from a Technical Board of Appeal at the EPO (European Patent Office) has resulted in the patent covering dasatinib being revoked. But why?